Sign In

Victor Velculescu

Professor at Johns Hopkins University School of Medicine, Founder of Delfi Diagnostics and PGDx

Dr. Victor Velculescu, MD, PhD, is a renowned figure in genomics and cancer research, recognized internationally for his groundbreaking discoveries.

He conducted the pioneering genome-wide sequence analysis in human cancers, revealing essential genes and pathways involved in tumorigenesis, leading to the identification of novel genes related to cancer development like PIK3CA.

Dr. Velculescu introduced innovative techniques for global gene expression studies, coining the term 'transcriptome' to describe cellular patterns in cancer and other cells.

His contributions have significantly impacted cancer treatment, paving the way for new FDA-approved therapies and diagnostic tests widely utilized by cancer patients globally.

Moreover, his recent work focuses on non-invasive liquid biopsy methods for the early detection and monitoring of cancer, revolutionizing cancer care and patient outcomes.

Educationally, he completed his B.S. in Biological Sciences at Stanford University and earned both his MD and PhD in Human Genetics and Molecular Biology from The Johns Hopkins University School of Medicine.

Professionally, Dr. Velculescu is the Founder & CEO of Delfi Diagnostics and has held key roles at prestigious institutions like The Johns Hopkins University School of Medicine, Harvard Cancer Center, CRUK, Ludwig Cancer Research, and the White House Cancer Moonshot initiative.

His vast experience includes serving as the Co-Director of Cancer Genetics and Epigenetics at The Sidney Kimmel Comprehensive Cancer Center and as a Professor of Oncology, Pathology, and Medicine at The Johns Hopkins University School of Medicine.

Additionally, he has been involved in numerous advisory boards, including those of Harvard Cancer Center, CRUK, Ludwig Cancer Research, Mark Foundation, and the American Association for Cancer Research.

Dr. Velculescu's research and leadership have significantly advanced the understanding of human cancer, benefiting patients worldwide with new treatment paradigms and diagnostic advancements.

Victor Velculescu
Add to my network

Location

Baltimore, Maryland